We are delighted to welcome eight new core-funded groups to the Vaccine Impact Modelling Consortium. These groups include modellers from Australia, Benin, Brazil, Kenya, Nigeria, Switzerland, Tunisia, and the UK. As shown below, we are joined by six new groups with disease-specific models of vaccine impact for COVID-19, hepatitis B... [Read More]

Imperial College London is seeking two Research Associates/Assistants to join the Vaccine Impact Modelling Consortium (VIMC)’s new research programme on the impact of climate change on vaccine-preventable diseases. Both are full-time, three-year posts. Research Assistant/Associate (Climate change impact on infectious diseases) Research Assistant/Associate in Malaria Modelling and Epidemiology The closing... [Read More]

Download our Guide for Applicants here. Download our FAQ here. The Consortium has opened a new Request for Proposals (RfP), as it seeks to recruit the following: groups with disease-specific models of vaccine impact for: malaria COVID-19 meningitis A / multivalent meningococcal conjugate vaccine (MMCV) hepatitis B other cross-cutting groups... [Read More]

The Vaccine Impact Modelling Consortium is delighted to have secured renewed funding of £12.8 million (USD $15.4 million) for the next five years, for a new phase of the project. Funding comes from the Bill & Melinda Gates Foundation; Gavi, the Vaccine Alliance; and the Wellcome Trust. This new phase... [Read More]

The Vaccine Impact Modelling Consortium (VIMC) and the University of Cambridge are running an intensive 6-day short course on Mathematical Modelling for Vaccine-preventable Diseases for participants from low and middle-income countries. The programme combines lectures, discussions and seminars with a series of in-depth practical sessions that help to facilitate understanding... [Read More]